Preferences help
enabled [disable] Abstract
Number of results
2014 | 9 | 1 | 159-168
Article title

Pathophysiological characterization of drug hypersensitivity to tribenoside

Title variants
Languages of publication
Physical description
1 - 2 - 2014
4 - 2 - 2014
  • 1st Department of Dermatovenereology, St. Anne’s University Hospital, Medical Faculty of Masaryk University, Brno, Czech Republic
  • 1st Department of Dermatovenereology, St. Anne’s University Hospital, Medical Faculty of Masaryk University, Brno, Czech Republic
  • Department of Clinical Immunology and Allergy, St. Anne’s University Hospital, Medical Faculty of Masaryk University, Brno, Czech Republic
  • Department of Clinical Immunology and Allergy, St. Anne’s University Hospital, Medical Faculty of Masaryk University, Brno, Czech Republic
  • [1] Hashizume H., Takigawa M., Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells, Acta Derm. Venereol., 2005, 85, 47–50[Crossref]
  • [2] Jaques R., The pharmacological activity of tribenoside, Pharmacology, 1977, 15, 445–460[Crossref]
  • [3] Kikkawa Y., Takaki S., Matsuda Y., Okabe K., Taniguchi M., Oomachi K., et al., The influence of Tribenoside on expression and deposition of epidermal laminins in HaCaT cells, Biol. Pharm. Bull., 2010, 33, 307–310[Crossref][WoS]
  • [4] Endo H., Kawada A., Yudate T., Aragane Y., Yamada H., Tezuka T., Drug eruption due to tribenoside, Contact Dermatitis, 1999, 41, 223[WoS][Crossref]
  • [5] Spáčil J., Pharmacotherapy of peripheral vascular diseases, In: Marek J. (Ed.), Pharmacotherapy of internal diseases, 3rd ed., Grada, Praha, 2005, 63–85
  • [6] Schuppli R., Exantheme durch Glyvenol, Dermatologica, 1968, 137, 227–232[Crossref]
  • [7] Barbaud A., Goncalo M., Bruynzeel D., Bircher A., Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions, Contact Dermatitis, 2001, 45, 321–328[Crossref]
  • [8] Inoue A., Tamagawa-Mineoka R., Katoh N., Kishimoto S., Allergic contact dermatitis caused by tribenoside, Contact Dermatitis, 2009, 60, 349–350[Crossref]
  • [9] Posadas S.J., Pichler W.J., Delayed drug hypersensitivity reactions - new concepts, Clin. Exp. Allergy, 2007, 37, 989–999[Crossref]
  • [10] Barbaud A., Drug patch testing in systemic cutaneous drug allergy, Toxicology, 2005, 209, 209–216[Crossref]
  • [11] Brockow K., Romano A., Blanca M., Ring M., Pichler W., Demoly P., General considerations for skin test procedures in the diagnosis of drug hypersensitivity, Allergy, 2002, 57, 45–51
  • [12] Wilkinson D.S., Fregert S., Magnusson B., Bandmann H.J., Calnan C.D., Cronin E., et al., Terminology of contact dermatitis, Acta Dermatovenereologica, 1970, 50, 287–292
  • [13] Pichler W., Yawalkar N., Schmid S., Helbling A., Pathogenesis of drug-induced exanthems, Allergy, 2002, 57, 884–893[Crossref]
  • [14] Pichler W.J., Tilch J., The lymphocyte transformation test in the diagnosis of drug hypersensitivity, Allergy, 2004, 59, 809–820[Crossref]
  • [15] Thon V., Eggenbauer H., Wolf H.M., Fischer M.B., Litzman J., Lokaj J., et al., Antigen presentation by common variable immunodeficiency (CVID) B cells and monocytes is unimpaired, Clin. Exp. Immunol., 1997, 108, 1–8[Crossref]
  • [16] Cederbrant K., Stejskal V., Broman P., Lindkvist L., Sundell K., In vitro lymphocyte proliferation in the diagnosis of allergy to phenoxymethylpenicillin, Allergy, 1998, 53, 1155–1161[Crossref]
  • [17] Sanz M.L., Gamboa P.M., De Weck A.L., In vitro tests: Basophil activation tests, In: Pichler W.J. (Ed.), Drug hypersensitivity, 1st ed., Karger, Basel, 2007, 391–402
  • [18] Sanz M.L., Gamboa P.M., Antépara I., Uasuf C., Vila L., Garcia-Avilés C., et al., Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics, Clin. Exp. Allergy, 2002, 32, 277–286[Crossref]
  • [19] Sioufi A., Pommier F., Biotransformation of tribenoside into benzoic acid in man, Eur. J. Drug Metab. Pharmacokinet., 1982, 7, 223–228[Crossref]
  • [20] Gregus Z., Fekete T., Halászi E., Gyurasics Á., Klaassen C.D., Effects of fibrates on the glycine conjugation of benzoic acid in rats, Drug metabolism. and disposition., 1998, 26, 1082–1088
  • [21] Bell-Parikh L.C., Guengerich F.P., Kinetics of cytochrome P450 2E1-catalyzed oxidation of ethanol to acetic acid via acetaldehyde, J. Biol. Chem., 1999, 274, 23833–23840[Crossref]
  • [22] Amunom I., Stephens L.J., Tamasi V., Cai J., Pierce W.M. Jr., Conklin D.J., et al., Cytochromes P450 catalyze oxidation of alpha, beta-unsaturated aldehydes, Arch. Biochem. Biophys., 2007, 464, 187–196[WoS][Crossref]
  • [23] Jacob S.E., Stechschulte S., Eyelid dermatitis associated with balsam of Peru constituents: benzoic acid and benzyl alcohol, Contact Dermatitis, 2008, 58, 111–112[WoS][Crossref]
  • [24] Rietschel R.L., Fowler J.F., Allergic sensitization to plants, In: Rietschel R.L., Fowler J.F. (Eds.), Fisher’s Contact Dermatitis, 6th ed., BC Decker Inc., Ontario, 2007, 405–453
  • [25] Avalos-Peralta P., García-Bravo B., Camacho F.M., Sensitivity to Myroxylon pereirae resin (balsam of Peru). A study of 50 cases, Contact Dermatitis, 2005, 52, 304–306[Crossref]
  • [26] Tanaka S., Matsumoto Y., Dlova N., Ostlere L.S., Goldsmith P.C., Rycroft R.J. G., et al., Immediate contact reactions to fragrance mix constituents and Myroxylon pereirae resin, Contact Dermatitis, 2004, 51, 20–21[Crossref]
  • [27] Rajpara S., Wilkinson M.S., King C.M., Gawkrodger D.J., English J.S.C., Statham B.N., et al., The importance of propolis in patch testing-a multicentre survey, Contact Dermatitis, 2009, 61, 287–290[Crossref][WoS]
  • [28] Friedmann P.S., Lee M.S., Friedmann A.C., Barnetson R.C., Mechanisms in cutaneous drug hypersensitivity reactions, Clin. Exp. Allergy, 2003, 33, 861–872[Crossref]
  • [29] Nyfeler B., Pichler W.J., The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity, Clin. Exp. Allergy, 1997, 27, 175–181[Crossref]
  • [30] Hari Y., Frutig-Schnyder K., Hurni M., Yawalkar N., Zanni M.P., Schnyder B., et al., T cell involvement in cutaneous drug eruptions, Clin. Exp. Allergy, 2001, 31, 1398–1408[Crossref]
  • [31] Bruynzeel D.P., Maibach H.I., Patch testing in systemic drug eruptions, Clinics in Dermatology, 1997, 15, 479–484[Crossref]
  • [32] Gex-Collet C., Helbling A., Pichler W.J., Multiple drug hypersensitivity - proof of multiple drug hypersensitivity by patch and lymphocyte transformation tests, J. Invest. Allergol. Clin. Immunol., 2005, 15, 293–296
  • [33] Merk H.F., Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines, Toxicology, 2005, 209, 217–220[Crossref]
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.